#Remdesivir is a medicine that fights viruses. It has been shown to prevent the virus that causes #COVID19 (SARS-CoV-2) from reproducing. Medical regulators have approved remdesivir for emergency use to treat people with COVID-19. cochranelibrary.com/cdsr/doi/10.10… 2/5
The @CochraneHaem authors found 5 studies w 7452 people hospitalised w #COVID19. Of these, 3886 people were given #remdesivir. Average age of patients: 59. Studies took place around the world, mainly in high- and upper-middle-income countries. cochranelibrary.com/cdsr/doi/10.10… 3/5
Kelly Ansems, @CochraneHaem: "Remdesivir probably has little or no effect on all-cause mortality at up to 28 days in hospitalised adults w SARS-CoV-2 infection. We are uncertain about the effects of #remdesivir on clinical improvement and worsening." cochranelibrary.com/cdsr/doi/10.10… 4/5